Scarica l'app Stockscreener
17.10
4.58%
-0.82
Dopo l'orario di chiusura:
17.20
0.10
+0.58%
Precedente Chiudi:
$17.92
Aprire:
$18.09
Volume 24 ore:
1.60M
Relative Volume:
1.45
Capitalizzazione di mercato:
$1.16B
Reddito:
$2.73B
Utile/perdita netta:
$-1.13B
Rapporto P/E:
-1.0263
EPS:
-16.6622
Flusso di cassa netto:
$-83.00M
1 W Prestazione:
-17.91%
1M Prestazione:
-27.48%
6M Prestazione:
-40.15%
1 anno Prestazione:
-51.97%
Intervallo 1D:
$17.08
$18.63
Intervallo di 1 settimana:
$17.08
$20.24
Portata 52W:
$17.08
$38.99
Quidelortho Corporation Stock (QDEL) Company Profile
Nome
Quidelortho Corporation
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
17.10 | 1.16B | 2.73B | -1.13B | -83.00M | -16.66 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corporation Borsa (QDEL) Ultime notizie
QuidelOrtho Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Why Is QuidelOrtho (QDEL) Down 24.5% Since Last Earnings Report? - Yahoo Finance
QuidelOrtho (QDEL) Valuation Check After Prolonged Share Price Weakness And Earnings Challenges - Yahoo Finance
QuidelOrtho Corp. Hits New 52-Week Low at $18.94 Amid Ongoing Struggles - Markets Mojo
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $19.24 - Markets Mojo
QuidelOrtho Corp. Forms Death Cross, Signaling Potential Bearish Trend - Markets Mojo
Chipmakers Recap: Will QuidelOrtho Corporation benefit from AI trends2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Stock Recap: Is QuidelOrtho Corporation a defensive stock2026 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow (NASDAQ:QDEL) 2026-03-09 - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Hits New 1-Year LowHere's Why - MarketBeat
Rice Hall James Buys QuidelOrtho Stock - The Motley Fool
Rice Hall James Buys QuidelOrtho Stock - The Motley Fool
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes shares are falling, what you need to know - MSN
Rate Cut: Is QuidelOrtho Corporation a turnaround story2025 Bull vs Bear & Weekly High Conviction Trade Ideas - baoquankhu1.vn
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
American Century Companies Inc. Raises Stock Position in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho at Raymond James Conference: Strategic Growth Insights - Investing.com Nigeria
QuidelOrtho at Raymond James Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
QuidelOrtho Stock Challenges: Revenue, Cash Flow, and ROIC TrendsNews and Statistics - IndexBox
A Look At QuidelOrtho (QDEL) Valuation After New Lifotronic Supply Agreement - Sahm
QuidelOrtho Corporation (QDEL) Stock Analysis: Potential Upside of Over 50% Amidst Strategic Positioning in Healthcare - DirectorsTalk Interviews
Segall Bryant & Hamill LLC Sells 71,044 Shares of QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
Vanguard Group Inc. Has $224.89 Million Stock Position in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corp reports results for the quarter ended March 31Earnings Summary - TradingView
QuidelOrtho (QDEL) Q4 2025 Earnings Transcript - AOL.com
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires - AOL.com
QuidelOrtho Corporation (NASDAQ:QDEL) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), QuidelOrtho (QDEL) and Akebia Therapeutics (AKBA) - The Globe and Mail
QuidelOrtho Q4 2025 slides: Revenue beats expectations despite 27% EPS drop - Investing.com Nigeria
Should QuidelOrtho’s (QDEL) Lifotronic Immunoassay Expansion Require Action From QDEL Investors? - simplywall.st
Why The QuidelOrtho (QDEL) Story Is Shifting As Analysts Rework Growth And Valuation Assumptions - Yahoo Finance
Is QuidelOrtho Corporation a defensive stockJuly 2025 Price Swings & Verified Swing Trading Watchlists - baoquankhu1.vn
Has QuidelOrtho (QDEL) Become A Potential Opportunity After Its Sharp Share Price Slide - simplywall.st
QuidelOrtho Corp. Stock Hits Day Low of $21.14 Amid Price Pressure - Markets Mojo
QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 63.60% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Earnings Miss: Is QuidelOrtho Corporation a defensive stock2025 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know - Finviz
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2025 earnings call transcript - MSN
Quidelortho Faces Material Risk from Weak Internal Controls and Sarbanes–Oxley Compliance Challenges - TipRanks
Decoding QuidelOrtho Corp (QDEL): A Strategic SWOT Insight - GuruFocus
Can QuidelOrtho’s (QDEL) Lifotronic Deal Reshape Its Global Immunoassay Competitiveness Story? - Yahoo Finance
Faster Cardiac Answers with High‑Sensitivity Troponin - PR Newswire
QuidelOrtho and Lifotronic agree on global immunoassay portfolio expansion - MSN
QuidelOrtho (NASDAQ:QDEL) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
QuidelOrtho Corp SEC 10-K Report - TradingView
QuidelOrtho Earnings Call: Growth, Margins And Risks - TipRanks
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference - marketscreener.com
The Top 5 Analyst Questions From QuidelOrtho's Q4 Earnings Call - Finviz
QuidelOrtho Partnership Targets Expanded Immunoassay Reach in International Markets - TipRanks
QuidelOrtho–Lifotronic Partnership Targets Global Immunoassay Expansion - TipRanks
Quidelortho Corporation Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):